IE 11 is a very old Browser and it`s not supported on this site
de en
Annual Report 2024
de en
Business reportPerformance/Multi-year comparison

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Annual performance

31.12.2024

SHARE

NAV

NBI TR

2024

(13.5%)

3.0%

7.6%

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

Cumulated performance

31.12.2024

SHARE

NAV

NBI TR

1 year

(13.5%)

3.0%

7.6%

3 years

(46.4%)

(15.1%)

(6.9%)

5 years

(30.7%)

(6.6%)

11.0%

10 years

22.8%

16.9%

31.6%

since inception 1)

1 612%

1 918%

1 293%

1 09.11.1993

Annualized performance

31.12.2024

SHARE

NAV

NBI TR

1 year

(13.5%)

3.0%

7.6%

3 years

(18.8%)

(5.3%)

(2.4%)

5 years

(7.1%)

(1.4%)

2.1%

10 years

2.1%

1.6%

2.8%

since inception 1)

9.5%

10.1%

8.8%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Annual performance

31.12.2024

SHARE

NAV

NBI TR

2024

(14.1%)

1.7%

6.3%

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

Cumulated performance

31.12.2024

SHARE

NAV

NBI TR

1 year

(14.1%)

1.7%

6.3%

3 years

(41.0%)

(6.3%)

2.8%

5 years

(21.0%)

7.7%

28.2%

10 years

54.6%

49.4%

68.5%

since inception 1)

1 467%

1 763%

1 459%

1 10.12.1997

Annualized performance

31.12.2024

SHARE

NAV

NBI TR

1 year

(14.1%)

1.7%

6.3%

3 years

(16.1%)

(2.2%)

0.9%

5 years

(4.6%)

1.5%

5.1%

10 years

4.5%

4.1%

5.4%

since inception 1)

10.7%

11.4%

10.7%

1 10.12.1997

Multi-year comparison

2024

2023

2022

2021

2020

Market capitalization at the end of the period (in CHF mn)

1 961.2

2 368.4

3 058.1

4 274.1

4 107.9

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

2 286.3

2 323.2

2 686.1

3 283.5

3 887.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

974.0

906.3

1 482.0

2 101.0

2 315.6

highchart-toggle

Profit/(loss) (in CHF mn)

75.9

(206.6)

(357.8)

(404.8)

691.2

highchart-toggle

Closing price at the end of the period in CHF

35.40

42.75

55.20

77.15

74.15

highchart-toggle

Closing price at the end of the period in EUR

37.45

45.50

56.70

74.05

68.00

highchart-toggle

Stock performance (incl. distributions) 1)

(13.5%)

(18.1%)

(24.3%)

8.3%

19.3%

highchart-toggle

High/low share price in CHF

49.35/35.30

60.70/35.60

78.15/51.00

92.20/73.40

74.70/45.44

highchart-toggle

High/low share price in EUR

52.00/37.45

60.50/37.10

75.40/49.60

86.20/67.80

69.00/43.04

highchart-toggle

Premium/(discount) (annual average)

(6.6%)

7.5%

20.5%

19.5%

9.2%

highchart-toggle

Dividend in CHF (*proposal)

1.80*

2.00

2.85

3.85

3.60

highchart-toggle

Degree of investment (quarterly figures)

111.3%

113.7%

112.8%

108.6%

106.8%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.33%

1.34%

1.27%

1.22%

1.25%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization